Medochemie

MEDOCHEMIE was established in 1976 in Cyprus by Dr. Andreas Pittas and is still driven by the same philosophy: "To provide every human being around the globe with quality and affordable drug treatment in a manner that supports sustainability". The company develops, license, manufacture, market, and distribute branded generic and super-generic pharm... aceutical products as well as the company's own patented brands. The journey has seen the company's active expansion into promising markets across the world - from the company's base in Europe, to the Middle East & Africa, through to the Far East. Outside the company's 20 core offices, the company developed a network of trusted agents and partners allowing the company to operate in 106 countries. Today, Medochemie Ltd has thirteen manufacturing plants and facilities. Nine are in Cyprus, one in the Netherlands, and three in Vietnam. The company has acquired and maintain 3,800 marketing authorization licenses for 630 different pharmaceutical products, classified in over 10 therapeutic categories. The company operates in accordance with the strictest quality standards and in full compliance with European guidelines. The driving force behind Medochemie is the company's 1,370 multinational, talented, quality-focused employees, who work in the company's manufacturing plants and offices worldwide. Medochemie is a founding member of the Medicines for Europe.Read More